Mark Sabat

Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.

Biswanath De, R. Bookland, Michael P Clark, 2006, Bioorganic & medicinal chemistry letters.

Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2.

Biswanath De, R. Walter, R. Bookland, 2006, Bioorganic & medicinal chemistry letters.